IMARC Group, a leading market research company, has recently released a report titled “Oncology Active Pharmaceutical Ingredients (APIs) Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global oncology active pharmaceutical ingredients market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How Big is the Oncology Active Pharmaceutical Ingredients (APIs) Market?
The global oncology active pharmaceutical ingredients (APIs) market size reached US$ 44.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 64.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.7% during 2023-2028.
What is Oncology Active Pharmaceutical Ingredients (APIs)?
Oncology API refers to an application programming interface (API) that provides access to oncology-related data, functionalities, or services. It allows developers to integrate oncology-specific features into their applications, such as retrieving cancer-related information, accessing treatment guidelines, managing patient data, or facilitating communication between different healthcare systems. Oncology APIs serve as the backbone of numerous chemotherapy drugs and targeted therapies, representing a pivotal aspect of the pharmaceutical industry's relentless pursuit to combat cancer effectively.
What are the Growth Prospects and Trends in the Oncology Active Pharmaceutical Ingredients (APIs) Industry?
As the incidence of various cancer types continues to rise, pharmaceutical companies are compelled to invest heavily in research and development (R&D) to create innovative oncology APIs that promise enhanced therapeutic outcomes thereby propelling the market demand. Moreover, the growing emphasis on personalized medicine is leading to a surge in demand for targeted therapies, which rely heavily on precisely engineered oncology APIs thus impelling the market growth. Furthermore, regulatory agencies worldwide are becoming increasingly stringent in their approval processes for cancer medications, necessitating the development of high-quality APIs that meet stringent safety and efficacy standards thus favoring the market growth. In line with this, the trend toward combination therapies, where multiple oncology APIs are used in tandem to address the complexity of cancer, is gaining traction. This approach offers a more comprehensive and effective means of treating various forms of cancer, further fueling market growth. In addition to this, the rising geriatric population is more susceptible to cancer, which is leading to a higher demand for oncology drugs and APIs to cater to the healthcare needs.
What is Included in Market Segmentation?
The report has categorized the market based on drug type, manufacturer type, type of synthesis and indication.
Breakup by Drug Type:
- Innovative Oncology APIs
- Generic Oncology APIs
Based on Manufacturer Type:
- Captive Manufacturers
- Merchant Manufacturers
Analysed by Type of Synthesis
- Synthetic Oncology APIs
- Biotech Oncology APIs
Market by Indication:
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Stomach Cancer
- Liver Cancer
- Esophagus Cancer
- Cervical Cancer
- Others
Regional Analysis:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Who are the Key Players Operating in the Oncology Active Pharmaceutical Ingredients (APIs) Market?
The report has also analysed the competitive landscape of the market along with the profiles of the key players.
Request For a PDF Sample Report: https://www.imarcgroup.com/oncology-active-pharmaceutical-ingredients-market/requestsample
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800
Website: https://www.imarcgroup.com/
Follow us on twitter: @ImarcServices
LinkedIn: https://www.linkedin.com/company/imarc-group
